0,936  0,003  Lipoxygenase inhibitor
0,923  0,002  Monophenol monooxygenase inhibitor
0,915  0,004  15-Lipoxygenase inhibitor
0,812  0,004  NOS2 expression inhibitor
0,804  0,008  Antineoplastic (lung cancer)
0,806  0,016  Apoptosis agonist
0,782  0,005  12-Lipoxygenase inhibitor
0,787  0,014  Transcription factor NF kappa B inhibitor
0,777  0,006  Chemopreventive
0,773  0,019  Antiinflammatory
0,740  0,004  Skin whitener
0,721  0,003  Melanin inhibitor
0,727  0,017  Antineoplastic (breast cancer)
0,709  0,005  Antioxidant
0,684  0,005  Free radical scavenger
0,650  0,018  Antineoplastic (colorectal cancer)
0,649  0,018  Antineoplastic (colon cancer)
0,637  0,008  Caspase 3 stimulant
0,637  0,010  UGT1A9 substrate
0,629  0,005  Genotoxic
0,608  0,013  Antineoplastic (cervical cancer)
0,601  0,009  Antineoplastic (brain cancer)
0,591  0,010  Nitric oxide antagonist
0,584  0,012  AR expression inhibitor
0,580  0,013  Proliferative diseases treatment
0,585  0,022  Antibacterial
0,569  0,010  Antiprotozoal (Leishmania)
0,566  0,011  Antineoplastic (glioma)
0,568  0,017  Radioprotector
0,550  0,005  Antineoplastic (squamous cell carcinoma)
0,568  0,028  Antileukemic
0,565  0,030  Alzheimer's disease treatment
0,531  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,542  0,017  Cytostatic
0,538  0,016  Cardiovascular analeptic
0,525  0,005  Protein-tyrosine phosphatase inhibitor
0,534  0,018  Cardioprotectant
0,553  0,044  Caspase 9 stimulant
0,518  0,016  Antineoplastic (multiple myeloma)
0,512  0,013  Hypoxia-inducible factor 1 alpha inhibitor
0,525  0,028  Prostate cancer treatment
0,503  0,014  Antineoplastic (glioblastoma multiforme)
0,503  0,015  Hypoglycemic
0,511  0,025  Antihypercholesterolemic
0,506  0,021  Hepatic disorders treatment
0,496  0,013  UGT1A6 substrate
0,502  0,020  Antiosteoporotic
0,502  0,027  Bone diseases treatment
0,492  0,024  Spasmolytic
0,473  0,005  5-Lipoxygenase inhibitor
0,500  0,033  Immunosuppressant
0,475  0,010  Antineoplastic (carcinoma)
0,472  0,012  Myocardial infarction treatment
0,458  0,007  Lipid peroxidase inhibitor
0,500  0,050  Cyclophilin D inhibitor
0,500  0,050  Antidiabetic
0,454  0,008  Topoisomerase II inhibitor
0,476  0,030  Antineoplastic (ovarian cancer)
0,452  0,009  UGT1A3 substrate
0,462  0,029  Cytotoxic
0,445  0,013  UGT1A1 substrate
0,471  0,040  Histamine release inhibitor
0,488  0,059  Antineoplastic (solid tumors)
0,444  0,022  CYP1A2 inhibitor
0,440  0,020  Superoxide dismutase inhibitor
0,431  0,017  UDP-glucuronosyltransferase substrate
0,488  0,084  Alpha-glucosidase inhibitor
0,460  0,058  TNF expression inhibitor
0,404  0,011  Platelet adhesion inhibitor
0,414  0,021  Antineoplastic (renal cancer)
0,422  0,036  Antineoplastic (melanoma)
0,438  0,053  CYP3A4 substrate
0,404  0,021  Antineoplastic (osteosarcoma)
0,393  0,025  Antiparasitic
0,419  0,061  Antiprotozoal
0,384  0,027  Antidiabetic symptomatic
0,390  0,040  Antineoplastic (pancreatic cancer)
0,381  0,036  Antidiabetic (type 2)
0,376  0,033  Antiamyloidogenic
0,367  0,026  Antihypertriglyceridemic
0,340  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,353  0,019  Hepatoprotectant
0,370  0,038  Sensitization
0,380  0,048  ICAM1 expression inhibitor
0,361  0,030  Vasodilator
0,332  0,007  Antihemorrhagic
0,361  0,040  Antineoplastic (non-small cell lung cancer)
0,328  0,007  Heat shock protein 90 antagonist
0,323  0,005  Aromatase inhibitor
0,337  0,024  UGT1A4 substrate
0,321  0,015  NOS3 expression enhancer
0,328  0,023  Non-steroidal antiinflammatory agent
0,337  0,037  Transcription factor STAT3 inhibitor
0,375  0,077  Antipruritic, allergic
0,318  0,025  Antihypotensive
0,339  0,047  Chemoprotective
0,349  0,062  Streptokinase A inhibitor
0,294  0,008  Topoisomerase II alpha inhibitor
0,314  0,029  Antihelmintic
0,291  0,008  Antibacterial (Helicobacter pylori)
0,345  0,062  Antifungal
0,285  0,005  Electron transport complex I inhibitor
0,284  0,005  Gastritis treatment
0,337  0,062  Apoptosis antagonist
0,319  0,045  Antineoplastic (lymphoma)
0,317  0,044  Antineoplastic (liver cancer)
0,312  0,039  Antineoplastic (lymphocytic leukemia)
0,331  0,066  CYP2D6 substrate
0,285  0,021  Tubulin antagonist
0,322  0,061  Lipoprotein disorders treatment
0,300  0,042  Antineoplastic (sarcoma)
0,288  0,033  Antiviral (Influenza)
0,327  0,073  Antithrombotic
0,331  0,081  Antiprotozoal (Plasmodium)
0,340  0,092  Antiobesity
0,342  0,096  CYP2C19 inhibitor
0,271  0,028  Neurotrophic factor enhancer
0,246  0,004  Lipase inhibitor
0,252  0,016  Chelator
0,258  0,023  Antiviral (Influenza A)
0,263  0,035  Antimutagenic
0,293  0,064  UGT2B4 substrate
0,301  0,074  NOS3 expression inhibitor
0,265  0,039  VCAM1 expression inhibitor
0,288  0,063  Transcription factor STAT inhibitor
0,273  0,051  Antiulcerative
0,257  0,039  P-glycoprotein inhibitor
0,265  0,048  Antineoplastic enhancer
0,260  0,044  RNA-directed DNA polymerase inhibitor
0,293  0,079  Analeptic
0,290  0,081  Respiratory analeptic
0,255  0,052  Antiviral (HIV)
0,235  0,031  MAO inhibitor
0,216  0,013  Beta amyloid protein antagonist
0,235  0,032  Heat shock protein 90 alpha antagonist
0,271  0,070  DNA damaging
0,263  0,063  Antiglaucomic
0,284  0,086  Antimycobacterial
0,219  0,023  DNA polymerase I inhibitor
0,249  0,058  Amyloid beta aggregation inhibitor
0,262  0,071  Antipyretic
0,224  0,036  Amylase inhibitor
0,257  0,072  Vascular (periferal) disease treatment
0,191  0,008  CDC25A inhibitor
0,293  0,111  Ulceration
0,185  0,005  Ornithine decarboxylase inhibitor
0,206  0,027  Arachidonic acid antagonist
0,202  0,026  Topoisomerase I inhibitor
0,191  0,015  Dementia treatment
0,246  0,072  Angiogenesis stimulant
0,260  0,086  CYP2C19 substrate
0,186  0,014  Vascular dementia treatment
0,216  0,046  Diabetic nephropathy treatment
0,174  0,005  Ca(v)3.1 blocker
0,289  0,124  CYP2C9 inhibitor
0,230  0,068  Antimitotic
0,203  0,042  UGT2B15 substrate
0,202  0,041  Phospholipase A2 inhibitor
0,199  0,047  Antiviral (Herpes)
0,194  0,043  Interferon gamma antagonist
0,169  0,018  Estrogen antagonist
0,176  0,025  Antineoplastic antibiotic
0,160  0,012  Antiviral (SARS coronavirus)
0,160  0,012  Antiviral (Coronavirus)
0,294  0,146  Antiparkinsonian
0,262  0,116  Sodium/bile acid cotransporter inhibitor
0,159  0,014  Estrogen receptor beta antagonist
0,190  0,045  UGT2B10 substrate
0,208  0,065  Mutagenic
0,198  0,056  LDLR expression enhancer
0,239  0,098  Antituberculosic
0,221  0,082  Hypolipemic
0,184  0,048  UGT2B9 substrate
0,167  0,032  MAO B inhibitor
0,141  0,007  Neuraminidase inhibitor
0,173  0,043  Acetylcholinesterase inhibitor
0,142  0,013  Postmenopausal disorders treatment
0,217  0,090  Platelet antagonist
0,158  0,033  Microtubule formation inhibitor
0,186  0,063  Dual specificity phosphatase inhibitor
0,255  0,133  Antineoplastic (small cell lung cancer)
0,194  0,073  Carcinogenic
0,156  0,035  Coagulant
0,161  0,046  Antifungal (Cryptococcus)
0,179  0,068  Mcl-1 antagonist
0,155  0,047  Farnesoid X receptor antagonist
0,122  0,018  Estrogen receptor alpha antagonist
0,137  0,032  Beta glucuronidase inhibitor
0,157  0,053  Cyclooxygenase 1 inhibitor
0,187  0,084  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,174  0,073  UGT2B7 substrate
0,140  0,045  Glutathione S-transferase substrate
0,129  0,034  Breast cancer-resistant protein inhibitor
0,192  0,098  Teratogen
0,228  0,134  GST M1-1 substrate
0,104  0,015  CDC25B inhibitor
0,154  0,067  Antidiarrheal
0,107  0,022  Leukotriene synthesis inhibitor
0,108  0,025  Na+ K+ transporting ATPase inhibitor
0,104  0,023  HIV-1 integrase inhibitor
0,097  0,017  Neuraminidase (influenza) inhibitor
0,096  0,018  Estrogen agonist
0,108  0,031  Antibiotic
0,172  0,095  CYP2B6 inhibitor
0,197  0,122  Immunostimulant
0,121  0,047  Mediator release inhibitor
0,170  0,098  Abortion inducer
0,094  0,024  Beta tubulin antagonist
0,078  0,008  Pregnane X receptor antagonist
0,106  0,038  Alpha 2d adrenoreceptor antagonist
0,107  0,040  Actinic keratosis treatment
0,145  0,081  Cholinergic
0,159  0,096  Succinate dehydrogenase inhibitor
0,169  0,106  Embryotoxic
0,089  0,027  Leukotriene antagonist
0,122  0,063  Cholesterol synthesis inhibitor
0,122  0,062  Alcohol dehydrogenase substrate
0,078  0,019  Transcription factor RelA inhibitor
0,133  0,074  Bone formation stimulant
0,148  0,090  Prostatic (benign) hyperplasia treatment
0,187  0,131  Antiprotozoal (Trypanosoma)
0,106  0,050  UGT2B11 substrate
0,101  0,047  Bile acid receptor antagonist
0,086  0,031  HIV-1 integrase (3'-Processing) inhibitor
0,100  0,048  Thioredoxin inhibitor
0,086  0,037  Peroxisome proliferator-activated receptor gamma agonist
0,222  0,175  CYP2C9 substrate
0,066  0,019  Glucose-6-phosphate translocase inhibitor
0,065  0,018  Vanilloid 2 antagonist
0,105  0,061  Urease inhibitor
0,128  0,084  Neurotrophic factor
0,060  0,017  Cathepsin L2 inhibitor
0,063  0,024  Leukotriene B4 antagonist
0,147  0,109  Antineoplastic (gastric cancer)
0,188  0,152  Antineoplastic (bladder cancer)
0,041  0,005  Inosine monophosphate dehydrogenase 1 inhibitor
0,056  0,021  Cholesterol esterase inhibitor
0,117  0,084  Antiacne
0,063  0,032  Ca(v)3.2 blocker
0,061  0,034  Fatty acid synthase inhibitor
0,078  0,051  Keratolytic
0,046  0,020  Estrogen receptor beta agonist
0,090  0,065  ABCA1 expression enhancer
0,126  0,103  Thrombolytic
0,132  0,109  Ca2+-transporting ATPase inhibitor
0,056  0,034  Alpha tubulin antagonist
0,122  0,103  SULT1A3 substrate
0,060  0,042  HIV-1 integrase (Strand Transfer) inhibitor
0,098  0,080  Mucolytic
0,174  0,155  Huntington's disease treatment
0,040  0,023  Retinoid X receptor antagonist
0,046  0,033  Potassium channel Kv1.3 blocker
0,051  0,038  Aldose reductase inhibitor
0,116  0,104  Cyclooxygenase inhibitor
0,023  0,011  Retinoic acid alpha receptor antagonist
0,192  0,180  Angiogenesis inhibitor
0,034  0,023  Retinoid X alpha receptor antagonist
0,078  0,068  Androgen antagonist
0,032  0,023  Estrogen-related receptor beta antagonist
0,114  0,104  Antineoplastic (uterine cancer)
0,193  0,184  CTGF expression inhibitor
0,034  0,026  Retinoid X alpha receptor agonist
0,098  0,091  TRPA1 agonist
0,149  0,144  Pneumotoxic
0,090  0,086  HDL-cholesterol increasing
0,082  0,078  MAO A inhibitor
0,182  0,180  CYP1A2 substrate
0,020  0,019  Leukotriene B4 receptor 2 antagonist
0,068  0,067  SULT1A2 substrate
0,024  0,023  Leukotriene B4 receptor 1 antagonist

